HIVAging
Meeting category
Date(s)
13 Oct 2022 - 14 Oct 2022
Meeting type
Virtual Meeting
CME Credits
4
Organizer
Platinum Level Sponsor
Sponsor logos
ViiV Logo

International Workshop on HIV & Aging 2022

Related Enduring Materials

Enduring Materials
The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.

Thursday, 13 October 2022

Session 1: Biological Aging -
How Are We Measuring Aging/Which Different Methods Are Used to Assess Aging?
Luigi Ferrucci, MD, PhD
National Institute on Aging (NIA), United States
Use of Senolytics as Modifiers of Aging Trajectory
James Kirkland, MD, PhD
Mayo Clinic, United States
#1 - Early Interruptions in Treatment Among PLHIV Over 50 Years of Age Starting Antiretroviral Therapy in PEPFAR-Supported Low and Middle-Income Countries
Deidra Parrish
United States
#2 - Persistent CD38 Expression on CD8+ T Lymphocytes Contributes to Chronic Inflammation in People With HIV, Despite ART
Poonam Mathur
United States
#3 - Tenofovir Alafenamide Is Associated With Shorter Telomere Length in People With HIV
Upal Roy
United States
Session 2: Neurocognitive Impairment in Aging PLWHIV -
Overlap Between HAND and Alzheimer Disease
Eliezer Masliah, MD
National Institute on Aging (NIA), United States
Overlap Between Cognitive and Physical Frailty
Mary Clare Masters, MD
Northwestern Memorial Hospital, United States
#4 - Increasing Neuroinflammation Relates to Increasing Neurodegeneration in PWH
Azin Tavasoli
Iran
#5 - Individual and Community Measures of Depression and Risk of Non-communicable Disease Among Adults With HIV
Jessica Castilho
United States
#6 - Social and Co-morbid Determinants of Brain Aging in Persons With and Without HIV
Kalen Petersen
United States
Guided Poster Tours (3 Parallel Sessions)
Guided Poster Tour 1 - CVD and Related Interventions
#24 - A Clinical Study of Non-Invasive Early Cardiovascular Disease Risk Assessment in the Hispanic Population Living with HIV
Douglas Salguero, United States
#25 - An Exploration of the Role of Intersectional Stigma and Discrimination on Cardiovascular Risk, Among Aging Women With HIV
Lunthita Duthely, United States
#26 - Glucose Changes Among Aging Female PWH in Southeast United States
Jennifer Kuretski, United States
#46 - Exploring Experiences With Exercise From the Perspectives of Women Living With HIV: A Qualitative Study
Nora Sahel-gozin, Canada
Guided Poster Tour 2 - Loneliness and Isolation
#31 - HIV, Social Networks, and Loneliness among Older-Aged People in Uganda
Lien Quach, United States
#40 - Selecting a Virtual Platform to Attenuate Social Isolation Among Older People Living With HIV: Lessons Learned From Community-Engaged Consultation
Erik Ruiz, United States
#42 - United Voices: Feasibility and Acceptability of a Virtual Choir Intervention for Older People with HIV during COVID-19
Judy Tan, United States
#53 - Social Support Network Factors Linked to Neuropsychological Performance Among Disadvantaged Persons Living With HIV Who Use Drugs: Implications for Multi-Level Intervention on Cognitive Impairment Linked to HIV
Amy Knowlton, United States
Guided Poster Tour 3 - COVID and Aging
#34 - Effects of the COVID-19 Pandemic on Quality of Life: Cross-Sectional Study of Older-Age People With and Without HIV in Rural Uganda
Brianne Olivieri-Mui, United States
#37 - Frailty Transitions in People With Post-Acute COVID Syndrome
Jovana Milic, Italy
#50 - Telehealth Access and Experiences of Older Adults With HIV During COVID-19
Emily Reyes, United States

Friday, 14 October 2022

Mentoring Lecture -
Mentoring Lecture
Beau Ances, MSc, MD, PhD, FANA, FAAN
Washington University in Saint Louis, United States
Lightning Poster Presentations -
#11 - Frailty and Physical Performance Assessments as Part of a Comprehensive Geriatric Care Model in an Urban HIV Clinic
Uzoamaka Eke
United States
#12 - Evaluation of an Electronic Health Record-Based Frailty Index in People With and Without HIV in a Primary Care Setting
Jennifer Lam
United States
#13 - Risk Factors for Frailty in a Geriatric Cohort on Long Term Antiretroviral Treatment in Uganda
Phoebe Mbabazi
Uganda
#14 - Physical Frailty Among Older HIV-Positive and HIV-Negative Women in Mombasa, Kenya: A Cross-Sectional Study
Teresa Kinyari
Kenya
#15 - Assessing the Impact of HIV Status and Menstrual Abnormalities on Longitudinal Bone Density Loss in Women Living With and Without HIV
Shayda Swann
Canada
#16 - Hormonal Intervention Combined with Allopregnanolone Alleviates Premature Age-Related Comorbidities in Female Mice Exposed to Ovarian Failure and HIV-1 Tat
Alaa Qrareya
United States
#17 - Plasma Extracellular Vesicles and Cell-Free Mitochondrial DNA Are Associated With Cognitive Dysfunction in Treated Older Adults With HIV
Carrie Johnston
United States
#18 - Clinical Care Priorities and Service Needs Among Patients Aging with HIV in the Bronx, New York
Amanda Pierz
United States
#19 - Physical Functioning in Older People Living With HIV: STRONG Study
Kareshma Mohanty
United States
#20 - Alzheimer-Type Cerebral Amyloidosis in the Context of HIV Infection: Implications for a Proposed New Treatment Approach
Shibangi Pal
United States
Session 3: Emerging Complications with Aging (+/- HIV) -
Kidney Disease in Aging PLWHIV (Clinical Case Based)
Christina Wyatt, MD
Duke University, United States
#7 - The Impending African Challenge: Gaps in 95-95-95 Performance Herald an Emerging Double-Disease Burden of Ageing and HIV in Two High Burden Metropolitan Health Districts in South Africa
Candice Fick
South Africa
#8 - Aging and HIV: What Is the Gap Between Clinical Practice and Guideline Recommendations?
Giovanni Guaraldi
Italy
#9 - Needs and Involvement of HIV Specialists and Geriatricians in the Care of Older Adults with HIV. A National Survey
Fátima Brañas
Spain
#10 - New York State AIDS Institute Initiatives to Improve Care For Older People With HIV and Long-Term Survivors: An Example of a Government-Academic-Community Partnership
Daniel Belanger
United States
Session 4: Panel Discussion: Specialized Care for Aging PLWHIV -
Brief Introductory Lectures
Geriatric Clinic Structure in General
Angela Condo, MD
Icahn School of Medicine at Mount Sinai, United States
Neuro Assessments
Beau Ances, MSc, MD, PhD, FANA, FAAN
Washington University in Saint Louis, United States
Nutrition/Diet Quality Screening
Amanda Willig, PhD, RD
University of Alabama at Birmingham, United States
Polypharmacy/Drug Interactions
Nancy Sheehan, PharmD, MSc
Université de Montréal and McGill University Health Centre, Canada
Physical Function/Physical Activity
Luigi Ferrucci, MD, PhD
National Institute on Aging (NIA), United States
Patient Perspective
Jules Levin, MS
National AIDS Treatment Advocacy Project, United States
Panel Discussion; Sharing Experiences / Best Practice
Overview
Welcome
Virtual Group Photo - HIV & Aging 2022

The 13th International Workshop on HIV & Aging took place as a virtual meeting from 13-14 October 2022.

The International Workshop on HIV & Aging 2023 will will take place from 26-27 October 2023 in the United States.

The integration of antiretroviral therapy (ART) into HIV care has dramatically extended the life expectancy of those living with HIV. This increased life expectancy is changing the demographics of the HIV epidemic. Currently, over half of individuals living with HIV are aged 50 or older. Recent estimates in Europe suggest that more than 70% of those with HIV will be over the age of 50 by 2030, accompanied by a greater burden of comorbidities and the associated treatments. In comparison to similar populations, persons with HIV, even when on effective ART, experience an excess of morbidity and mortality. Complications due to AIDS are rarely fatal for persons on ART. Instead, patients experience an early onset of aging complications, including neurocognitive decline, osteoporosis and fractures, impaired physical function, frailty, and falls.

Improving the management of older adults with HIV will require a much deeper understanding of the interface between aging, HIV, associated comorbid conditions, and concurrent treatment. Additionally, research is needed to address the unique psychosocial challenges faced by this growing population. The elderly population living with HIV is particularly vulnerable to social stigma, which can lead to depression, psychological distress, compromised adherence to therapy, and overall poor treatment outcomes and quality of life.

The International Workshop on HIV and Aging remains the only platform worldwide for international, cross-disciplinary scientific exchange on the increasingly recognized difficulties encountered in the clinical care and design of studies to improve the care of persons aging with HIV. The meeting gathers (basic) researchers, healthcare professionals across different disciplines, and community advocates to foster dialogue and prompt solutions that will benefit the aging population living with HIV. In addition, the workshop will also create opportunities for trainees and junior investigators to present their research, network, and learn from experts in the field.

Chairs
CME Accreditation
The International Workshop on HIV & Aging 2022 Utrecht (Livestream), Netherlands, 13/10/2022 - 14/10/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 4 European CME credits (ECMEC®s). Each medical specialist should claim only those credits that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Unique Features
• Two-day virtual meeting
• Invited lectures from international experts
• Interactive roundtable discussions
• Ample time for discussion
Who Should Attend?
Internal Medicine specialists (clinicians working in cardiovascular, renal, endocrine, and metabolic complications of HIV areas), infectious disease specialists, (virologists, immunologists, pharmacologists), geriatricians, neurologists, epidemiologists, geneticists and other clinical researchers; community advocates, industry representatives.
Meeting Objectives
The meeting objectives for this workshop are to:

- Facilitate an unbiased and scientific knowledge exchange regarding HIV and aging, and encourage early-career investigators to actively partake in the workshop;

- Summarize and promote the current state of the science regarding HIV and aging and its successful translation and dissemination;

- Identify future challenges and catalyze research and awareness.
Learning Objectives
After attending this workshop, participants will be able to:

- Outline the impact of anti-inflammation agents in chronic inflammation on aging in PLWHIV;

- Describe the biological aging concepts and approaches to use to measure and monitor aging;

- Categorize the manifestations of neurocognitive impairment and their effect on frailty;

- Inform on the role geriatric clinics can play in providing dedicated care.

Practical Information 

Certificate of Attendance
A certificate of attendance will be sent to participants after they have attended the workshop and completed the post-meeting survey.
Language
The official language of the workshop is English. Translation will not be provided.
Virtual Platform
The link to access the workshop will be shared closer to the start date.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The conference secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.
Liability and Insurance
By registering for the workshop participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs as well as audio and video recordings are not permitted at the official workshop sessions. Only the official medical writer, appointed by the organization, may make recordings. All presentations, will be posted on the workshop website (under Workshop Materials) as soon as possible after the workshop is finished, provided that the speaker has provided permission to do so.
Media Representation
For rates and conditions, please visit the registration page of this workshop.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.

Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration

Registration is now closed.

Please note that payment by credit card is required to be able to register for the workshop. Please contact the conference secretariat if this is not possible for you.

Fees & Conditions

Academia

Industry*

Early Fee (payment before/ on 13 April 2022)

$237.50

$1675.00

Regular Fee (payment before/ on 9 October 2022)

$477.50

$2155.00

Onsite Fee / Post-Meeting Fee (payment from 10 October 2022) 

$537.50

$2275.00

Discounts

Early-Career Investigators and/or Academia from Resource-Limited Settings (RLS)** WITH an accepted abstract

100% Off Early Academia Fee

Early-Career Investigators and/or Academia from Resource-Limited Settings (RLS)** WITHOUT an accepted abstract, NGO Representatives/ Government Representatives (i.e. NIH, NIAID, CDC, etc) / Community Advocates

50% Off Current Academia Fee

Academia from High-Income Countries*** WITH an accepted abstract

Early Academia Fee

Representatives of Sponsoring Industry / Endorsing Organizations

Contact the Secretariat

*Industry representatives may receive a discount based on the level of support provided to the event. For more support and registration information, please contact us at christina.moustakaki@amededu.com

**Countries included in the low-income and middle-income economies of the World Bank Classification.

***Countries included in the high-income economies of the World Bank Classification.

Registration Fee Includes
- Access to all live stream sessions during the event; and

- All presentation materials as well as recordings 3 weeks after the event.
Important
No day rate is available.

Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.

We strongly advise that you register early to ensure your registration is confirmed. 

Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment, if applicable, has been received and a confirmation of your registration has been sent.
Cancellation Policy
In case of cancellation, the following refunds are applicable:

- Cancellation before/on 13 September 2022: 50% refund (minus an administration fee of $40)
- Cancellation after 13 September 2022: Unfortunately, no refund will be given

If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 31 September 2022. A statement (email/letter) of cancellation must be sent to Virology Education.
Media Registration
In order to register as a media participant for the workshop, the conference secretariat needs to receive:

1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop

A free or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.

We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.

Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2021 embargo policy.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Endorsers

HIV & Aging 2022 is endorsed by societies and organizations. Their support and collaboration are key to the success of this workshop!


A 25% discount on the academia registration fee is offered to members/employees of endorsers. Please reach out to your organization to obtain the applicable discount code.


If you would like your organization to endorse this workshop, please contact Christina Moustakaki at Christina.Moustakaki@amededu.com

Committees

The members of the Organizing Committee (OC) are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts. 

Organizing Committee
Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee (OC) and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

  • Dorcas Baker, RN, BSN, ACRN, MA, Johns Hopkins University School of Nursing, MidAtlantic AIDS Education and Training Center (AETC), United States
  • Bruce Brew, MD, St Vincent's Hospital, Australia
  • Marie-Josée Brouillette, MD, McGill University Health Centre, Canada
  • Simon Collins, HIV i-Base, United Kingdom
  • Daniel Duprez, MD, University of Minnesota (Cardiology), United States
  • Giovanni Guaraldi, MD, Policlinico Modena, Italy
  • Jordan  Lake, MD, MSc, UTHealth, United States
  • Alan Landay, PhD, Rush University Medical Center, United States
  • Catia Marzolini, PharmD, PhD, University Hospital Basel, Switzerland
  • Eugènia Negredo, MD, PhD, Universitat Autònoma de Barcelona , Spain
  • Kelly O'Brien, PhD, BScPT, BSc, University of Toronto, Department of Physical Therapy, Canada
  • Brendan Payne, PhD, Newcastle University, United Kingdom
  • Molly Perkins, PhD, Emory University School of Medicine, United States
  • Matilde Sanchez Conde, MD, PhD, Hospital Ramón y Cajal, Spain
  • Eugenia Siegler, MD, Weill Cornell Medicine, United States
  • Jeff Taylor, HIV + Aging Research Project - Palm Springs, United States
  • Phyllis Tien, MD, MSc, University of California, San Francisco, United States
  • Cara Wilson, MD, University of Colorado, United States
Industry LIaison Board

The Industry Liaison Board, consisting of leading medical scientists of the pharmaceutical industry, is asked to give input and suggestions that help the Organizing Committee in planning the workshop and providing support on topics of interest and innovative suggestions to optimize audience participation. The Industry Liaison Board assists the Organizing Committee by suggesting the most current and critical topics to bring the audience up-to-date on the most current research in the pharmaceutical industry in related disciplines.

  • Andrew Clark, MD, ViiV Healthcare, United Kingdom
  • Richard Haubrich, MD, Gilead Sciences, United States
  • Christian Marsolais, PhD, Theratechnologies, Canada

Support
Platinum Level
Silver Level

Supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP

__________________________________________________________________________

Symposium
Aging and Inflammation, From Science to Clinical Relevance

This satellite symposium was presented by:

ViiV Healthcare, United Kingdom

Agenda | Thursday, 13 October 2022 -
Basic Concepts on Inflammation Linking It to Aging (+/- PLWHIV)
Peter Hunt, MD
University of California San Francisco, United States
Inflammation, Aging, and End-Organ Disease in People with HIV
Scott Letendre, MD
University of California – San Diego, United States
Chronic Inflammation in Older People with HIV: Assessment and Management Approach​
Julian Falutz, MD, FRCPC
McGill University, Canada
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Reports
Previous Editions
Language
Ratings previous edition
Content is relevant to my practice
4.2
(111)
Content was free from commercial bias
4.6
Overall event experience
4.0